<DOC>
	<DOCNO>NCT00043407</DOCNO>
	<brief_summary>CPG 7909 give alone patient renal cell cancer nephrectomy . CPG 7909 subcutaneous injection per week 24 week . Up 40 patient include study .</brief_summary>
	<brief_title>CPG 7909 Patients Wih Stage IV Renal Cell Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Stage IV Renal Cell Carcinoma lung and/or soft tissue metastasis Nephrectomy Measurable disease RECIST criterion CNS , bone Liver metastasis Tumors mainly papillary , chromophobe , medullary , collect duct , unclassified Prior immunotherapy , include IL2 IFNalpha</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Renal Cell Carcinoma , Phase I , Phase II , Immunotherapy</keyword>
</DOC>